 |
|
African HIV Subtypes Identified in Minnesota Population
May 31, 2005Public health researchers in Minnesota recently identified 83 persons infected with subtypes of HIV-1 that are not common in the United States, according to a report published in the June 15 issue of The Journal of Infectious Diseases, now available online.
Viral subtype identification may be important because subtypes may differ in terms of the efficacy of potential vaccines, diagnostic testing for HIV infection, and monitoring of the health of HIV-infected patients. The report, by Tracy L. Sides, MPH, and colleagues of the Minnesota Department of Health and the HIV Program at Hennepin County Medical Center, emphasizes the need for better surveillance of HIV-1 subtypes to determine their prevalence.
For the first two decades of the AIDS epidemic in the United States, HIV-1 subtype B has been the predominant isolate throughout the country. In recent years, non-B HIV-1 subtypes have been spreading in parts of Europe. As Sides and colleagues explained, however, the prevalence of subtype B and other subtypes in the United States is not known, because subtype testing is not conducted with routine HIV/AIDS surveillance.
In 2003, the Minnesota Department of Health piloted HIV-1 subtyping with routine surveillance to describe and monitor non-B-subtype HIV-1 isolates. In Minnesota, African-born persons make up less than one percent of the population, but in 2002 accounted for 21 percent of the state's new cases of HIV infection. Accordingly, Sides and colleagues conducted targeted surveillance of 98 African-born HIV-infected patients to determine the existence and variety of HIV-1 subtypes. They also conducted surveillance on 28 non-African patients to monitor the introduction of non-B subtypes into Minnesota.
All of those infected with non-B subtypes were African immigrants attending health clinics in the Minneapolis-St. Paul area. Of the 98 African-born HIV-1-infected patients, 87 were successfully subtyped and 95 percent of these were infected with non-B subtypes. Seven different subtypes were identified, all consistent with strains endemic to the patients' regions of birth. Of the non-African HIV-1-infected patients, 25 were successfully subtyped and all were infected with subtype B.
The researchers believe that their results underestimate the prevalence of non-B subtypes in Minnesota because recent immigrants are less likely than assimilated immigrants to have access to the American health care system. Since their estimates are based solely on patients from health care facilities, they probably missed recent immigrants with HIV infection.
In an accompanying editorial, Diane Bennett, MD, MPH, of the Centers for Disease Control and Prevention explained that this study is important because few such investigations of U.S. subtype prevalence have been conducted, and because the results have national public health implications. "The findings of a high prevalence of non-B subtypes in a state where African-born individuals make up less than one percent of the population," she said, "suggest that it may be time to consider implementing HIV subtype surveillance in states with larger immigrant populations and throughout the United States."
Infectious Diseases Society of America
In 2003, the Minnesota Department of Health piloted HIV-1 subtyping with routine surveillance to describe and monitor non-B-subtype HIV-1 isolates. In Minnesota, African-born persons make up less than one percent of the population, but in 2002 accounted for 21 percent of the state's new cases of HIV infection. Accordingly, Sides and colleagues conducted targeted surveillance of 98 African-born HIV-infected patients to determine the existence and variety of HIV-1 subtypes. They also conducted surveillance on 28 non-African patients to monitor the introduction of non-B subtypes into Minnesota.
All of those infected with non-B subtypes were African immigrants attending health clinics in the Minneapolis-St. Paul area. Of the 98 African-born HIV-1-infected patients, 87 were successfully subtyped and 95 percent of these were infected with non-B subtypes. Seven different subtypes were identified, all consistent with strains endemic to the patients' regions of birth. Of the non-African HIV-1-infected patients, 25 were successfully subtyped and all were infected with subtype B.
The researchers believe that their results underestimate the prevalence of non-B subtypes in Minnesota because recent immigrants are less likely than assimilated immigrants to have access to the American health care system. Since their estimates are based solely on patients from health care facilities, they probably missed recent immigrants with HIV infection.
In an accompanying editorial, Diane Bennett, MD, MPH, of the Centers for Disease Control and Prevention explained that this study is important because few such investigations of U.S. subtype prevalence have been conducted, and because the results have national public health implications. "The findings of a high prevalence of non-B subtypes in a state where African-born individuals make up less than one percent of the population," she said, "suggest that it may be time to consider implementing HIV subtype surveillance in states with larger immigrant populations and throughout the United States."
Infectious Diseases Society of America
HIV-1 Current Events and HIV-1 News RSSHoping for a fluorescent basket case
Although recent advances have raised hopes that a protective vaccine can be developed, acquired immunodeficiency syndrome (AIDS) remains a major public health problem.
Maternal HIV-1 treatment protects against transmission to newborns
Mothers receiving highly active antiretroviral therapy (HAART) to treat HIV-1 infection are less likely than untreated mothers to transmit the virus to their newborns through breastfeeding.
Scientists join forces to explain HIV spread in Central and East Africa
Scientists studying biology and geography may seem worlds apart, but together they have answered a question that has defied explanation about the spread of the HIV-1 epidemic in Africa.
Researchers induce HIV-neutralizing antibodies that recognize HIV-1 envelope protein, lipids
For the first time, researchers have experimentally induced antibodies that neutralize HIV-1 and simultaneously recognize both HIV-1 envelope protein and lipids.
Link uncovered between viral RNA and human immune response
In its fight against an intruding virus, an enzyme in our immune system may sense certain types of viral RNA pairs, according to scientists.
In vitro antibody production enables HIV infection detection in window period -- key to safer blood
Researchers in Israel and Kenya have shown that the contribution of variable degrees of immune suppression, either due to existing chronic infections such as parasitemias and/or nutrition, in different populations may influence and prolong the serological-diagnostic window period of HIV.
AIDS discovered in wild chimpanzees
Although the AIDS virus (HIV-1) entered the human population through chimpanzees, scientists have long believed that chimpanzees don't develop AIDS.
Penn-Wistar team gains insight into HIV vaccine failure
A team of researchers from The Wistar Institute and the University of Pennsylvania reports new evidence refuting a popular hypothesis about the highly publicized failure in 2007 of the Merck STEP HIV vaccine study that cast doubt on the feasibility of HIV-1 vaccines.
Genetic Variation Associated With Survival Advantage in African Americans With HIV
From the start of the HIV epidemic, it appeared that some of the people who were infected with the virus were able to ward off the fatal effects of the disease longer than others.
Study offers insights into failed HIV-1 vaccine trial
Following the disbandment of the STEP trial to test the efficacy of the Merck HIV-1 vaccine candidate in 2007, the leading explanation for why the vaccine was ineffective - and may have even increased susceptibility to acquiring the virus - centered on the hypothesis that high levels of baseline Ad5-specific neutralizing antibodies may have increased HIV-1 acquisition among the study subjects who received the vaccine by increasing Ad5-specific CD4+ T-cells that were susceptible to HIV-1 infection.
More HIV-1 Current Events and HIV-1 News Articles
 |
HIV-1: Molecular Biology and Pathogenesis: Viral Mechanisms, Volume 55, Second Edition (Advances in Pharmacology) by Kuan-Teh Jeang (Editor), J. Thomas August (Editor), Ferid Murad (Editor) This volume covers the latest advances in the mechanisms of pathogenesis of the HIV-1 virus on target cells. Its companion volume, Advances in Pharmacology 56, shows how new developments in understanding the virus translate to the clinical setting. |
 |
Biro Directed By: Ntare Guma Mbaho Mwine |
 |
How to Lose a Guy in 10 Days: Day 1 - Sorry Baby, I Got the Hiv Bear Party (Primary Contributor) |
 |
Home Access HIV - 1 Test System - 1 ea by Home Access Please note: Due to packaging updates, the image shown may temporarily appear different |
|
Neutral Disinfectant Cleaner, Kills Over 120 Viruses, Including Hepatitis, Hiv, Flu, German Measles, Herpes Simplex and Many More. Cleans and Disinfects!. 1 Galllon Concentrate Makes 65 Gallons of Ready to Use Product by Misco This Gallon Cleaner is very Concentrated. 1 Gallon Makes 65 Gallons Of Ready To Use Product. This disinfectant is Great for our whole house! Use it i n your Kitchen, Bathroom tile floors, Stainless Steel and much more. It Kills Over 120 Viruses. | |
 |
Actualizaciones Sobre El Sida (The Latest Facts About HIV and Aids) Region 1 & 4 - Import Latin-america Directed By: PETER COCHRAN Este programa explica, a través de material gráfico, entrevistas con enfermos y con expertos, cómo se contrae el VIH y cómo se desarrolla el SIDA, a la par que brindan indicaciones claras sobre medidas preventivas y los tratamientos actuales que mejores resultados están alcanzando. Se presentan también los nuevos métodos de detección, que permiten obtener información preliminar el mismo día, aunque es preciso realizar una confirmación posteriormente. Se aclara que, aun si los medicamentos que se prescriben hoy en día tienen en general menores efectos secundarios y permiten desarrollar una mejor calidad de vida, no todos los enfermos reaccionan bien ante ellas, por lo que es preciso mantener el cuidado y no ponerse en riesgo. |
 |
Lutron S600H-IV Electronics Skylark Dimmer, Ivory by Lutron Ivory, Single Pole Slide Dimmer, Skylark Designer Style, Slide To Off, Full Range Dimming, 600W Capacity, Wallplate Not Included, UL Listed, CSA Certified, Clam Shell Package. |
 |
1.02ct Cushion Cut Center HI-VS2 EGL Certificate This 1.02 carat Cushion cut diamond is set on a 14kt white gold ring with 0.20 carats of round diamonds. With a total carat weight of 1.22 |
|
HIV-1 MedMira Ab Test (50 per box) by MedMira | |
 |
Gundam Mg Rx-93-V2 Hi-V Gundam 1/100 Scale Model Kit by Bandai Originally appearing in the "Beltorchika's Children" novel, the Hi-Nu Gundam finally makes its plastic kit debut in Bandai's popular Master Grade series. Considered one of the most powerful mobile suits in the Universal Century timeline, Hi-Nu Gundam is a completed version of the prototype Nu Gundam that appeared in "Mobile Suit Gundam: Char's Counterattack," and comes armed with a beam rifle, beam sabers, shield, and an enhanced Nu hyper bazooka for some truly devastating offensive attacks. It also features a revised fin funnel system that extend from the back like a pair of angelic wings; each fin funnel is detachable and can be displayed with the included effect parts as though it's flying towards its target and ready to fire! As usual with Master Grade kits, its inner body frame comes... |
| © 2009 BrightSurf.com |